Women Overseas Are Speaking Openly About Menopause. Why Are We Still Enduring It in Silence?
Community can make people feel less alone, while some posts funnel every concern toward one product. Keep the connection and your judgment.

In this article

The glass of water left in the office kitchen, and the sentence left unsaid
I. That remark in the office kitchen
Three in the afternoon, in the office kitchen. A colleague, Xiaolin, was holding a cup when she suddenly stopped, pressed the back of her hand against her cheek, and said, “Why am I getting hot again?”
Someone beside her replied, “You are not going through menopause, are you?”
The room paused for a second. Xiaolin smiled, said “Do not be silly,” and walked away. Her cup remained on the counter, its water unfinished.
In this scene, nobody did anything wrong. There was no malice, no humiliation, and nobody was even really joking. Yet that moment of silence is precisely the heart of the issue: in our everyday context, “menopause” remains a word that demands immediate denial. It can serve as material for teasing, but is difficult to discuss as a legitimate health topic.
At the same time, across the ocean, women of a similar age are doing the exact opposite. Speaking into their phone cameras, they say it out loud: their symptoms, their age, and their experiences of being dismissed by doctors. Then they post the video for hundreds of thousands, even millions, to see.
This article explores what has happened between this step forward and step back, and what it actually means for each of us.
II. A billion views: a shift from silence to speaking
Start with a few numbers.
1 billion+
Cumulative views of #menopause on TikTok have exceeded the billion-view scale
35–45 years
The core group joining this discussion is much younger than the traditional age associated with menopause

The moment you put the phone face down is where things truly begin
What does a billion views mean? On this platform, “menopause” is no longer an entry only women over fifty click. It has become a public topic women in their twenties, thirties, and early forties actively search for, follow, and share. Many have not reached menopause, or even the typical age of perimenopause, but are already learning in advance.
Approximately 46%
The proportion of women who refer to social-media content when making health-related decisions: a midpoint estimate across several European and US surveys, with exact values varying by survey definitions
This figure deserves a pause. Nearly half of women include social-platform content in their health decision-making chain. This is not simply because “they are easily deceived.” There is a more basic fact: when formal healthcare does not deliver information promptly and adequately, people look for it themselves. The place they find it happens to be where algorithms recommend it most frequently, expression is most vivid, and emotional resonance is strongest.
The initiating event: a change in a regulatory document
This wave did not appear from nowhere. It has a relatively clear starting point.
In 2025, the US Food and Drug Administration (FDA) announced the removal of the “boxed warning” from labeling for menopausal hormone therapy products. A boxed warning is the most serious warning level in US prescription-drug labeling, usually indicating potentially life-threatening risks. After the Women's Health Initiative (WHI) results were published in 2002, menopausal hormone therapy was rapidly “demonized” in public perception, use fell precipitously, and many women and doctors avoided it over the following two decades.
Once that most severe warning was removed, a chain reaction followed almost immediately. Medical statements changed, the media reopened the discussion, and people on social media who had long wanted to speak finally had an authoritative reference to cite. A key turning point
One point needs to be clear:
Removing a boxed warning does not mean “hormone therapy has been shown to suit everyone and carry no risk.” Its precise meaning is that, after reassessing all evidence, the regulator considered the previous blanket highest-level warning disproportionate to the strength of current evidence. Risks should be discussed through individualized assessment rather than a warning box that keeps everyone out. The difference is crucial.
This produced an interesting time lag: scientific consensus at the regulatory level was corrected slowly, while emotional expression in the public sphere erupted instantly. The former took twenty years; the latter took two. When those curves crossed around 2025, they created today's situation in which “menopause is suddenly everywhere.”
Why TikTok rather than the hospital?
It is worth asking why this surge of discussion happened on short-video platforms rather than in consultation rooms.
The reasons are not complicated. First, short videos have very low distribution costs: a 30-second video can reach millions, while a consultation reaches one person and her family. Second, short videos naturally allow similar people to gather. Someone describing hot flashes and sweating immediately attracts hundreds of “me too” comments, providing instant validation that traditional medical settings can rarely offer. Third, and most importantly, you do not first have to acknowledge that you are “ill.”
You can simply watch because it appears in your feed. You can like it completely anonymously. You can observe how others speak before deciding whether it applies to you. This “low-commitment path of exploration” bypasses the hardest cultural barrier: the psychological cost of admitting face to face, “I may be approaching menopause.”
In other words, social platforms can accommodate such huge demand precisely because the entrance to formal channels is too steep.
III. Evidence review: what do we know about this wave?
The available evidence can roughly be divided into three layers.
Layer one: strong evidence for the prevalence and underrecognition of menopause
Chinese women begin perimenopause at an average age of 46. Natural menopause averages 48 to 52, and approximately 90% reach menopause between 45 and 55. These figures come from the 2023 Chinese Guideline on Menopause Management and Menopausal Hormone Therapy, with a clear source and defined scope.
More important is symptom burden. The guideline notes that approximately 80% of women experience at least one menopause-related symptom during perimenopause, commonly fatigue and weakness, irritability, sleep disturbance, musculoskeletal and joint pain, and hot flashes or sweating. The characteristic symptom of hot flashes and sweating lasts a median of 4.5 years—not a few months, but four and a half years.
In other words, this is no small issue that “passes if you endure it.” It is a physiological process lasting years and involving multiple body systems.
Layer two: equally strong evidence for the gap in seeking care
25.97%
The proportion of symptomatic women who actually sought hospital care in a 2020 survey in a Shanghai community; formally cited in the 2023 Chinese menopause-management and MHT guideline
That survey studied 3,147 women aged 40 to 60 in a Shanghai community, conducted by Du Li and colleagues at the Shanghai maternal and child health center. It showed that only about a quarter entered a hospital; the rest chose silence and endurance. Sleep disturbance was the leading reason for seeking care—not hot flashes or mood, but sleep problems. This itself is revealing: many people are finally “forced” into hospital only once symptoms seriously interfere with basic quality of life.
The impression from frontline practice is starker than the statistics. In public reporting, one doctor estimated that of approximately 200 million women aged 40 to 65, only around 10% reach a hospital.
Layer three: the reliability of the social-media wave itself—here views diverge
In July 2026, MIT Technology Review published an article with a notably blunt title: “There's a lot of hype around perimenopause. Don't buy it.”
It raised two key objections. First, there is currently no reliable test for perimenopause. Because hormones fluctuate dramatically during the transition, a single blood value may be high today and low tomorrow. “Confirming perimenopause” with one laboratory test is methodologically unsound. Second, the wave already showed some cult-like features: a specific vocabulary, defined camps, high trust in internal authorities, and rejection of outside questions.
“More attention means the problem has been solved.”
More attention means that
channels of expression
have opened, rather than that
quality of care
has improved. Several barriers lie between them: whether information is accurate, whether viewers act, whether they can find the right doctor, and whether that doctor can respond effectively.
Attention ≠ awareness ≠ action ≠ access to appropriate care. The first two steps have improved; the last two have largely remained unchanged.
Critics' concerns are not baseless. When content creators compete commercially over a health topic, three distortions inevitably arise: symptoms become generalized, so almost any discomfort can be explained as “perimenopause”; solutions become simplified, reducing complex individualized medicine to lists of “take this, avoid that”; and questions are silenced, with professionals offering reservations labeled “unempathetic.”
Those three issues are precisely what the next two articles will explore in detail.
IV. Risks and controversies: why being able to speak is not enough
At this point, we need to speak more directly. The value and limitations of this wave are two sides of the same coin.
It has genuinely solved the hardest first step
Redefining menopause from “private shame” into a life stage that can be discussed publicly is profoundly important. A central difficulty for Chinese women has never been as simple as “not knowing hormone therapy exists.” It is embarrassment about speaking, not knowing whom to tell, and fear of being dismissed as “making a fuss.” Behind the earlier estimate that “only around 10% reach hospital” are many women who never consider themselves patients at all.
Here, online discussion has a real effect. For the first time, someone realizes “I am not the only one,” and learns that this is not a character flaw, insufficient strength, or attention-seeking. That shift in understanding is the prerequisite for all later action.
But speaking and receiving support are a long way apart
The problem is that popularity does not automatically become quality care. Consider where this chain is most likely to break.
Break one, information: “everyone says it” does not mean “it is correct”
Short videos are judged by reach, not accuracy. A piece reducing complex evidence to a slogan spreads much more efficiently than one honestly explaining “the evidence here is still limited.” The platform's information ecosystem therefore favors certainty, strong conclusions, and simple causation. Menopause, however, is highly individualized and full of uncertainty.
Break two, decisions: from “I am watching” to “I will act”
Most people encountering content stop at “now I know.” Turning online awareness into an appointment requires overcoming many barriers: which specialty, whether a doctor will say nothing is wrong, cost, and taking time off. Failure at any one leaves action stalled.
Break three, care: entering the hospital does not guarantee a response
This is the most easily overlooked and most consequential step. Even after finally reaching a hospital, a person may encounter a doctor unfamiliar with the topic or one who assigns the symptoms elsewhere. When a consultation provides no response, she often retreats online, where alternatives are generally easier to access and cheaper than appropriate clinical care.
Taken together, these breaks reveal something: social media's real risk lies less in what it gets wrong than in filling a vacuum healthcare should have filled. A vacuum will not remain empty; something will fill it. If we do not want it filled by product selling, pseudoscience, and exaggerated narratives, the only way is to repair entry into formal services, rather than argue with people online.
A boundary that must be explicit
Online content can help you understand menopause, recognize whether medical assessment may be needed, and prepare questions for your doctor.
It cannot diagnose you, decide medication for you, or replace individualized benefit–risk assessment. Every drug intervention, including menopausal hormone therapy, has indications, contraindications, and circumstances requiring caution. Your treating physician must assess these using history, examination, and relevant tests. There are no exceptions.
An overlooked perspective: who is left out of this wave?
Participation in this discussion is uneven. People who speak actively on English-language social platforms and become visible to algorithms tend to have more education, stronger English skills, leisure, and a voice. Meanwhile, people whose symptoms may be worse, access to care harder, and cost of silence greater—women in underserved communities, midlife family caregivers, and manual workers—are precisely those least likely to appear in this chorus.
This is why “women overseas are speaking openly about menopause” cannot simply be copied as our solution. A topic becoming visible is one thing; who becomes visible is another. If discussion ultimately benefits only people who already have resources, its actual impact is limited.
V. Practical advice: turn encountering a post into asking a doctor
After all this, what can we do? The following checklist aims to turn online understanding into a high-quality in-person consultation.
Step one: decide whether to seek assessment, rather than first deciding whether you are ill
- You are over 40 and have noticeable menstrual-cycle changes—earlier or later periods, or changes in flow—or
- You have hot flashes, sweating, poor sleep, mood swings, aching joints or muscles, palpitations, chest tightness, or other discomfort that already affects work, sleep, or relationships
Either is reason for formal assessment. The criterion here is “affects life,” rather than “meets a disease definition.” Do not diagnose yourself first, or exclude possibilities on the doctor's behalf.
Step two: know where to go, and what to do if no appointment is available
- First choice: a hospital with a menopause or gynecologic endocrinology clinic. Some Chinese institutions now provide these services; 42 were nationally designated menopause-care specialty services according to 2023 data.
- Second choice: a gynecology clinic or one focusing on gynecologic endocrinology.
- If none is available: book general gynecology and proactively say, “I suspect this may relate to menopause,” raising the topic rather than waiting to be asked.
Step three: prepare four things before the consultation
- A symptom record: when symptoms began, frequency, aggravating circumstances, and impact on life. Two weeks of phone notes are much more accurate than on-the-spot recall.
- A menstrual log: dates, duration, and changes in flow over the last six to twelve months.
- Medical history and a medication list: especially breast conditions, thrombosis, liver or kidney disease, and all current medicines and supplements.
- Specific questions, written down: “Do I need further tests?” “If medication is considered, what assessments do I need first?” “How often should I return?” “What would mean I need to come back immediately?”
Step four: treat the visit as shared decision-making rather than an examination
You have the right to know why a doctor suggests a test, why a treatment is recommended or not, the strength of evidence behind the recommendation, alternatives, and each option's benefits and risks. If a consultation does not provide a convincing explanation, asking another doctor is entirely legitimate. This is not “being difficult”; it is taking responsibility for yourself.
About follow-up:
Once treatment begins, regular review is essential to its long-term effectiveness and safety. Guidelines recommend at least one comprehensive annual benefit–risk assessment for women using menopausal hormone therapy. Follow-up is therefore part of the plan, rather than an “extra burden.”
VI. Conclusion: the real “coming out” happens in the consultation room
Return to the office kitchen at the beginning.
If one day Xiaolin says again, “Why am I getting hot?” and the reply is “Have you seen someone about it? It is worth getting checked,” rather than “You are not going through menopause, are you?”—then this small conversation beyond the billion views will genuinely have changed.
This is the central point: public discussion is progress, but being able to say it has never meant it can be solved through short videos.
Freeing the topic from shame is a remarkable achievement. It tells countless women for the first time that their discomfort has a name, is recognized, and can be addressed. But if we stop there—if “finding peers online” replaces “finding a doctor in the clinic”—the wave merely moves endurance from offline to online. You still bear it alone, only this time with company in the comments.

The room that can actually support you: a chair, a white coat, a medical record
Social media helps with “acknowledgment.” The real “coming out” is sitting opposite a specific doctor and calmly, fully describing the feelings hardest to express. It means no longer saying “I have been a little tired,” but “I have slept poorly for three straight months, I have hot flashes during the day and joint pain, and I want to know whether this relates to menopause.”
No video can do that for you.
The good news is that it is easier than you think: prepare those four things, walk through the door, sit down, and speak.
One sentence to take home:
When a trending topic appears, do not rush to match and diagnose yourself. Turning its popularity into an appointment is what makes those billion views genuinely useful to you.
Sources
Menopause Group, Chinese Society of Obstetrics and Gynecology, Chinese Medical Association. Chinese Guideline on Menopause Management and Menopausal Hormone Therapy, 2023. Chinese Journal of Obstetrics and Gynecology, 2023, 58(1): 4-21. Source for average age at perimenopause onset, menopause-age distribution, 80% symptom prevalence, median hot-flash duration of 4.5 years, Shanghai community care-seeking rate of 25.97%, and related figures.
Du Li and colleagues, Shanghai maternal and child health center. Survey of care-seeking for menopausal symptoms among 3,147 women aged 40~60 in a Shanghai community, 2020, cited in reports by Lifeweek, Fujian Health News, and other media.
China Youth Daily client. “Expert: menopause clinic development is accelerating; seek care promptly when symptoms appear.” 2023-05-13. Source for 42 nationally designated menopause-care specialty services and the national number of menopausal women.
Guangming Online / Workers' Daily Online. “Women should guard against the long-term harms of menopause.” 2023. Zhang Huiying of Tianjin Central Hospital of Gynecology and Obstetrics discusses misconceptions about consultations and assessment procedures.
MIT Technology Review. “There's a lot of hype around perimenopause. Don't buy it.” July 2026. Critiques of the perimenopause wave: no reliable testing method and cult-like characteristics.
US Food and Drug Administration, 2025 announcement concerning removal of boxed warnings from menopausal hormone therapy products. Consult the original FDA website for the exact document number and implementation details.
On “approximately 46% of women consulting social media for health decisions”: this measure appears in multiple European and US health-communication surveys. Exact values and samples differ; it should be cited as an indication of scale rather than a precise figure.
This article is health education and does not constitute individualized diagnostic or treatment advice.
All investigations, medication decisions, and treatment plans discussed require your treating physician's integrated assessment of personal history, physical examination, and relevant additional tests. Do not start or stop medication independently based on this article.
Observational research and survey data cited here describe population-level phenomena only and cannot establish individual-level causal relationships.
Seek medical attention promptly if you experience significant discomfort or progressively worsening symptoms.
Read the source material
The original archive manuscript is restored above. These additional references offer context; their inclusion does not constitute medical validation of every original claim. Clinical and regional terminology review are pending.
A good question starts a conversation.
Explore a related editorial discussion. Reading is open to everyone; posting and replying require a free reader account.


